Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Treatments
Response to chemotherapy in metastatic breast cancer predicted with F-18-FDG PET
September 1st, 2005
Response to chemotherapy in metastatic breast cancer patients could be predicted with F-18-FDG PET. According to recent research from Germany, "Chemotherapy is currently the treatment of choice for patients with high-risk metastatic breast cancer. Clinical response is determined after several cycles of chemotherapy by changes in tumor size as assessed by conventional imaging procedures including CT, MRI, plain film radiography, or ultrasound." "The aim of this study was to evaluate the use of sequential F-18-FDG PET to predict response after the first and second cycles of standardized chemotherapy for metastatic breast cancer. Eleven patients with 26...
Source: Women's Health Weekly (2005-09-01)
|
